SERPINB5 (serine protease inhibitor b5), initially identified in breast cancer, serves as a tumor suppressor by suppressing metastasis and angiogenesis, as well as promoting cell adhesion and apoptosis (Mahananda et al., 2021). This evidence concerns the gene SERPINB5 and breast cancer.